Evidence map›Paper›PMID 38587386›Full record

ArticleJournal of visualized experiments : JoVE2024

Differentiation and Characterization of Osteoclasts from Human Induced Pluripotent Stem Cells.

Alexander Blümke, Jessica Simon, Elizabeth Leber, Marta Scatena, Cecilia M Giachelli

Abstract readVideo-Audio Media
In one paragraph

Article in Journal of visualized experiments : JoVE, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Alexander BlümkeDepartment of Bioengineering, Department of Medicine, University of Washington; Department of Orthopedics and Trauma Surgery, Medical Faculty Mannheim, Heidelberg University.
Jessica SimonDepartment of Bioengineering, Department of Medicine, University of Washington.
Elizabeth LeberDepartment of Bioengineering, Department of Medicine, University of Washington.
Marta ScatenaDepartment of Bioengineering, Department of Medicine, University of Washington.
Cecilia M GiachelliDepartment of Bioengineering, Department of Medicine, University of Washington; ceci@uw.edu.

Funding

Mechanisms of vascular and valvular calcificationR35HL139602 · NHLBI · UNIVERSITY OF WASHINGTON · PI GIACHELLI, CECILIA M · 2018 to 2023
$5.6M
Molecular and Cellular Regulation of Vascular CalcificationR35HL171342 · NHLBI · UNIVERSITY OF WASHINGTON · PI Cecilia M Giachelli · 2024 to 2026
$3.1M
Leica SP8 WWL Confocal MicroscopeS10OD016240 · OD · UNIVERSITY OF WASHINGTON · PI CATTERALL, WILLIAM A · 2014 to 2014
$581k
Acquisition of BD FACSymphony A3 Lite Flow CytometerS10OD024979 · OD · UNIVERSITY OF WASHINGTON · PI BLACK, MICHELE C · 2020 to 2020
$344k
NHLBI NIH HHS R35 HL139602NHLBI NIH HHS R35 HL171342NIH HHS S10 OD016240NIH HHS S10 OD024979
6 · The paper itself

Abstract

This protocol details the propagation and passaging of human iPSCs and their differentiation into osteoclasts. First, iPSCs are dissociated into a single-cell suspension for further use in embryoid body induction. Following mesodermal induction, embryoid bodies undergo hematopoietic differentiation, producing a floating hematopoietic cell population. Subsequently, the harvested hematopoietic cells undergo a macrophage colony-stimulating factor maturation step and, finally, osteoclast differentiation. After osteoclast differentiation, osteoclasts are characterized by staining for TRAP in conjunction with a methyl green nuclear stain. Osteoclasts are observed as multinucleated, TRAP+ polykaryons. Their identification can be further supported by Cathepsin K staining. Bone and mineral resorption assays allow for functional characterization, confirming the identity of bona fide osteoclasts. This protocol demonstrates a robust and versatile method to differentiate human osteoclasts from iPSCs and allows for easy adoption in applications requiring large quantities of functional human osteoclasts. Applications in the areas of bone research, cancer research, tissue engineering, and endoprosthesis research could be envisioned.

Indexed as

Bone ResorptionInduced Pluripotent Stem CellsBone and BonesCell DifferentiationHumansMacrophage Colony-Stimulating FactorMembrane GlycoproteinsOsteoclastsRANK LigandMacrophage Colony-Stimulating FactorMembrane GlycoproteinsRANK Ligand

Identifiers

PMID38587386
PMCPMC11108805

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.